Daiichi Sankyo Shutting UK Site As Global Cost Drive Continues
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo is taking another step in its worldwide R&D restructuring process by deciding to shut a UK development center near London that will affect around 80 positions.